Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

LABORATORY CORPORATION OF AMERICA HOLDINGS

(LH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

LABORATORY CORP OF AMERICA HOLDINGS : Submission of Matters to a Vote of Security Holders (form 8-K)

05/14/2021 | 04:10pm EDT

Item 5.07 Submission of Matters to a Vote of Security Holders.



The 2021 Annual Meeting of Shareholders (the "Annual Meeting") of Laboratory
Corporation of America Holdings (the "Company") was held on May 12, 2021. As of
March 24, 2021, the date of record for determining the Company's shareholders
entitled to vote on the proposals presented at the Annual Meeting, there were
97,640,861 shares of the Company's common stock issued and outstanding and
entitled to vote at the Annual Meeting. The holders of 86,897,605 shares of the
Company's issued and outstanding common stock were represented in person or by
proxy at the Annual Meeting, constituting a quorum. The proposals presented at
the Annual Meeting are described in detail in the Company's definitive proxy
statement filed with the Securities and Exchange Commission on April 2, 2021
(the "Proxy Statement"). The vote results detailed below represent final results
as certified by the Inspector of Elections.

Proposal 1.


The Company's shareholders elected the following persons, who were listed in the
Proxy Statement, to the Board to hold office for the term expiring at the 2022
Annual Meeting of Shareholders or until their successors are elected and
qualified or until their earlier death, resignation, or removal:



                                                              Votes                            Broker
                                           Votes For         Against        Abstentions       Non-Votes
Adam H. Schechter                           73,328,980       5,394,024           605,553       7,569,048
Kerrii B. Anderson                          71,597,149       7,686,664            44,744       7,569,048
Jean-Luc Bélingard                          75,027,417       4,254,725            46,415       7,569,048
Jeffrey A. Davis                            78,747,054         533,941            47,562       7,569,048
D. Gary Gilliland, M.D., Ph.D.              78,777,649         463,087            87,821       7,569,048
Garheng Kong, M.D., Ph.D.                   73,929,027       5,353,466            46,064       7,569,048
Peter M. Neupert                            70,817,397       8,461,869            49,291       7,569,048
Richelle P. Parham                          78,234,021       1,048,830            45,706       7,569,048
Kathryn E. Wengel                           79,166,291         119,091            43,175       7,569,048
R. Sanders Williams, M.D.                   74,258,864       4,982,197            87,496       7,569,048


Proposal 2.

The Company's shareholders approved, in an advisory (non-binding) vote, the compensation of the Company's named executive officers. The votes regarding this proposal were as follows:



               Votes                    Broker
Votes For     Against    Abstentions   Non-Votes
72,236,847   6,915,431     176,279     7,569,048


Proposal 3.

The Company's shareholders ratified the appointment of Deloitte & Touche LLP as
the Company's independent registered public accounting firm for the year ending
December 31, 2021. The votes regarding this proposal were as follows:



               Votes                   Broker Non-
Votes For     Against    Abstentions      Votes
85,261,770   1,587,455     48,380           0

--------------------------------------------------------------------------------

Proposal 4.


The Company's shareholders voted against the shareholder proposal seeking an
amendment to the Company's proxy access by-law to remove the aggregation limit.
The votes regarding this proposal were as follows:



               Votes                    Broker Non-
Votes For     Against     Abstentions      Votes
29,709,385   49,415,648     203,524      7,569,048

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about LABORATORY CORPORATION OF AMERICA HOLDINGS
06/14LABORATORY OF AMERICA  : OmniSeq Launch Genomic, Immune Profiling Test OmniSeq I..
MT
06/14LABORATORY OF AMERICA  : Labcorp And OmniSeq Launch INSIGHT℠, Next-Generat..
PR
06/09Labcorp Launches COVID-19 At-Home Test Kit at Walgreens
MT
06/08LABORATORY OF AMERICA  : Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit..
BU
06/07CORRECTION : Mizuho Securities Maintains Laboratory Corp of America Holdings PT ..
MT
06/07LABORATORY OF AMERICA  : Mizuho Securities Adjusts Laboratory Corp of America Ho..
MT
06/03LABORATORY OF AMERICA  : Labcorp to Introduce Combined Oncology Offering at 2021..
AQ
06/02LABCORP  : to Introduce Combined Oncology Offering at 2021 ASCO® Annual Meeting
BU
05/26LABORATORY CORP OF AMERICA HOLDINGS  : Entry into a Material Definitive Agreemen..
AQ
05/24LABCORP  : Study Suggests COVID-19 Antibodies Remain at Least 10 Months After In..
BU
More news